Biodelivery Sciences International Receivables

Biodelivery Sciences International (BDSI) currently reports a receivables of $57M as of December 2021. That compares with $48M in the prior-year period — up 18.1% year over year. Use the charts on this page to explore Biodelivery Sciences International's receivables history and peer comparisons.

Biodelivery Sciences International's receivables increased from $48M to $57M — a 18.1% year-over-year increase (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biodelivery Sciences International reported $57M in receivables as of December 2021. That compares with $48M in the prior-year period — up 18.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $57M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biodelivery Sciences International, and consider following BDSI for alerts when major investors trade the stock.

Biodelivery Sciences International is classified in the Healthcare sector. On receivables, it currently shows $57M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BDSI with unrelated industries.